Actions

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q4 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q4 FY25
Bearish
3
Neutral
4
Bullish
7
Bearish
31
Neutral
4
Bullish
11
Bearish
28
Neutral
0
Bullish
4
Bearish
3
Neutral
4
Bullish
7
Bearish
3
Neutral
4
Bullish
7
Bearish
28
Neutral
0
Bullish
4
Bearish
28
Neutral
0
Bullish
4
Bearish
28
Neutral
0
Bullish
4
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Personal Products
Personal Care
216 Cr
Moderate Risk
12.6
41.1
0.2
3.2
219.80
110.30
Sales CAGR
Profit CAGR
ROE
ROCE
Sat Kartar Life Ltd (SATKARTAR) is currently trading at 143.40 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Sat Kartar Shopping Limited specializes in Ayurveda healthcare, integrating traditional Ayurvedic knowledge with modern innovations to offer natural wellness solutions and lifestyle products. The company exhibited a robust revenue growth of 18% year-on-year, highlighting resilience amidst macro challenges such as the Indo-Pak tension, showing the scalability and future readiness of their business model. With the operational launch of their own manufacturing unit and strategic AI rollout, Sat Kartar signifies substantial expansion and innovation in both production and technological usage, setting a precedent in the Ayurveda market. Future growth strategies involve pivotal areas like the inception of Ayurveda hospitals, AI deployment for better customer insights, and manufacturing advancements, signaling a major transition to a holistic health and wellness ecosystem. The company's strong alignment with government initiatives like the National AYUSH Mission effectively positions it to leverage India’s growing demand for natural and organic therapeutic products.
Over the past 52 weeks, Sat Kartar Life Ltd has traded between a low of ₹110.30 and a high of ₹219.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Sat Kartar Life Ltd has a market capitalization of approximately 215.76. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Sat Kartar Life Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 12.62 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 215.76 Cr, Sat Kartar Life Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Sat Kartar Life Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Sat Kartar Life Ltd is 12.62. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.